Novartis Vaccines, the maker of Menveo®, is the world’s fifth-largest vaccines manufacturer, the second-largest supplier of influenza vaccines in the United States, and is creating innovative solutions to combat deadly diseases globally. In fact, every 25 seconds, someone in the world receives a Novartis vaccine.
Creating a community of wellness
At Novartis Vaccines, we believe that caring for patients begins with helping to protect individuals and societies from infection—and that the only thing better than finding a cure for a disease is preventing illness in the first place.
Dedicated to preventing meningococcal disease
Now we’ve put our energy and resources together to protect patients against this terrible disease. The result is Menveo, a meningococcal vaccine. Menveo has been shown to be safe and effective in preventing meningococcal disease, plus it requires only 1 dose at time of vaccination.1
